This paper describes a new, simple, and sensitive method for detecting two fluoroquinolones: enrofloxacin and its metabolite ciprofloxacin, which are widely used as drugs for humans and animals. We utilized gold nanoparticles (AuNPs) and laser desorption/ionization time-of-flight (LDI-TOF) mass spectrometry (MS) with a matrix-free format. An antibody for the drug was immobilized on a chip based on self-assembled monolayers (SAMs) on gold, and AuNPs were decorated with the drug along with a large excess of small molecules, called amplification tags (Am-tags). In this strategy, target drugs in solution bound to the antibody on the chip compete with the AuNP-immobilized drugs. The presence of targets was verified by the amplified LDI-TOF MS signals of Am-tags on AuNPs.
Introduction
Fluoroquinolones (FQs) are synthetic antibacterial agents that have a broad spectrum of activity against both Gram-negative and Gram-positive bacteria. They act by interfering with bacterial DNA-gyrase (a type-II topoisomerase) activity. 1, 2 FQs are one of the most important groups of synthetic antibiotics used for the treatment of bacterial infections in humans and livestock. Enrofloxacin is a member of the second-generation FQ family, and is used exclusively for animals. 3 Ciprofloxacin, a major metabolite of enrofloxacin, produced by deethylation of enrofloxacin, has been the most widely used antibacterial agent for both humans and animals since its introduction for clinical use in 1987. 4, 5 These two FQs are routinely prescribed for animals to prevent veterinary diseases; however, their multiple and widespread use could be responsible for resistance by such pathogens as Campylobacter, Salmonella, and E. coli, and residues in food of animal origin or farm wastes present potential risks to consumers. [6] [7] [8] A number of countries have therefore regulated the use of these two FQs for animal bred for food production; for example, the European Union and the United States have set maximum residue limits (MRLs) in edible tissues, milk, and eggs, and the use of these two drugs is restricted for laying hens. [9] [10] [11] Along with tightening up the regulations on FQ use, various analytical methods have been developed for determining or screening FQ residues, including high-performance liquid chromatography (HPLC), [12] [13] [14] liquid chromatography-mass spectrometry (LC/MS), 15, 16 enzyme-linked immunosorbent assays (ELISA), [17] [18] [19] [20] and capillary electrophoresis. [21] [22] [23] Although these methods are routinely used with high sensitivity, general use of these methods is sometimes hampered by the need for sophisticated and time-consuming processes. In this respect, a new method with a simple experimental protocol is demanded, while sustaining high sensitivity.
In this paper, we introduce a simple, fast, highly sensitive method for the detection of two major FQs, enrofloxacin and ciprofloxacin, by a mass signal amplification strategy using gold nanoparticles (AuNPs) and laser desorption/ionization time-offlight (LDI-TOF) MS (Fig. 1) . 24, 25 Our mass signal amplification strategy uses a small molecule, called an amplification tag (Am-tag), which is decorated on AuNPs in large excess along with the target drug. The target drug in solution then binds to an antibody on a biochip in competition with the AuNPimmobilized drug. After the competitive assay, the presence of the target is validated using LDI-TOF MS without an organic matrix, which allows high sensitivity by affording amplified mass signals stemming from the Am-tags.
Experimental

Reagents and chemicals
AuNPs (40 nm diameter) were prepared using a method reported by Schwartzberg et al. 26 Gold-coated coverslips were prepared by evaporation of titanium (5 nm) and then gold (15 nm), using an electron beam evaporator (Korea Vacuum, KVE T-C500200). Tri(ethylene glycol)-terminated alkanethiol and carboxylic penta(ethylene glycol)-terminated alkanethiol were synthesized using a method reported by Housman et al. 27 Enrofloxacin, ciprofloxacin, ethylenediamine, sodium borohydride, sodium citrate, cobalt chloride, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), dimethyl sulfoxide (DMSO), and N-hydroxysuccinimide (NHS) were purchased from Sigma-Aldrich (St. Louis, MO). Hydrogen tetrachloroaurate(III) hydrate (HAuCl4) was purchased from Kojima Chemicals Co., Ltd. (Sayama, Japan). Anti-enrofloxacin/ ciprofloxacin was purchased from Santa Cruz Biotechnology, Inc. (CA, USA). Absolute ethanol (≥99.9%) was purchased from Merck (Darmstadt, Germany). Phosphate buffered saline (PBS) was purchased from WelGene Biopharmaceuticals (Daegu, Korea).
Preparation of carboxylic acid-presenting monolayers
Gold-coated coverslips were cleaned in a Piranha solution (sulfuric acid:30% hydrogen peroxide = 70:30. WARNING: Piranha solution is highly corrosive and reactive. Handle with caution!) for 2 min, washed with deionized water and ethanol, and dried under a nitrogen stream. The coverslips were incubated in a mixed solution of tri(ethylene glycol)-terminated alkanethiol and carboxylic acid-terminated alkanethiol solution at ratios ranging from 95:5 for 12 h (the total concentration of the alkanethiol solution was 1 mM). The monolayers were washed with absolute ethanol and dried under a stream of nitrogen.
Preparation of antibody-presenting monolayers
The carboxylic acid-presenting monolayers (4 × 4 mm 2 ) were treated with solutions of EDC (5 μL, 20 mg/mL in PBS at pH 7.4) and NHS (5 μL, 5 mg/mL in PBS at pH 7.4) solutions for 2 h, washed with PBS, and dried under a nitrogen stream. The monolayer was treated with monoclonal antibody (10 μL, 0.6 μM in PBS at pH 7.4) for 1 h, washed with PBS and deionized water, and dried under a nitrogen stream. The monolayers were stored at 4 C until use.
Preparation of drug-immobilized AuNPs (enroAuNPs and ciproAuNPs)
As-made AuNPs (100 μL, 0.2 nM) were washed with absolute ethanol by centrifugation (13000g, 3 min), and incubated in an ethanolic solution of tri(ethylene glycol)-terminated alkanethiol and carboxylic acid-terminated alkanethiol in a ratio of 90:10 (100 μL; the total concentration of the alkanethiol solution was 100 μM) for 12 h and washed with absolute ethanol by centrifugation (13000g, 3 min) . The resulting carboxylic acidpresenting AuNPs were then incubated with NHS (200 μL, 5 mg/mL in phosphate buffer (PB) at pH 7.4) and EDC (200 μL, 20 mg/ml in PB at pH 7.4) for 2 h, and washed with PB.
Ethylenediamine (400 μL, 10 mM in 10% DMSO) was directly incubated with the NHS-activated AuNPs for 1 h to introduce amine functional groups on AuNPs. A solution of enrofloxacin (200 μL, 20 mg/mL in 10% DMSO) and EDC (200 μL, 20 mg/mL in PB at pH 7.4) was incubated with the resulting AuNPs for 2 h and washed with PB by centrifugation (13000g, 1 min). Ciprofloxacin (200 μL, 20 mg/mL in 10% DMSO) was immobilized by direct incubation for 2 h with the NHS-activated AuNPs prepared as mentioned above. The resulting enroAuNPs and ciproAuNPs were stored at 4 C.
Competitive assay
The drug-immobilized AuNPs (10 μL, 0.2 nM in PB at pH 7.4) were mixed with standard drug solutions at six different concentrations ranging from 0.05 to 50 mg kg -1 in PB at pH 7.4. The antibody-presenting monolayer (4 × 4 mm 2 ) was treated with this mixed solution for 1 h, rinsed twice with PBS and deionized water, respectively, and dried under a stream of nitrogen. The monolayer was then directly analyzed using LDI-TOF MS without an organic matrix.
Mass analysis
Mass analysis was performed with an Autoflex III MALDI-TOF mass spectrometer (Bruker Daltonics) equipped with a Smart beam TM laser as an ionization source. All the spectra were acquired at an accelerating voltage of 19 kV, with a 100 Hz repetition rate, in a positive mode, with an average of ~700 shots.
Results and Discussion
Our approach described here is based on self-assembled monolayers (SAMs) of alkanethiolates on gold chips and AuNPs, and takes advantage of the compatibility of SAMs on gold with matrix-assisted LDI-TOF (MALDI-TOF) MS. 28, 29 Specifically, alkanethiolates on AuNPs can be effectively analyzed without the use of an organic matrix to give the molecular weights of the constituents on AuNPs. Figure 2 shows the structure of the monolayers used in this experiment as well as the chemical modifications employed to prepare antibody-presenting chips and drug-immobilized AuNPs, enroAuNPs and ciproAuNPs. Antibody-presenting chips were prepared using carboxylic acid-presenting monolayers at a density of 5% amongst tri(ethylene glycol)-terminated alkanethiolates. The carboxylic acid on the monolayer was treated with EDC and NHS, resulting in an NHS-activated ester, which subsequently reacted with the amine functionality of the monoclonal antibody (Fig. 2a) . Two FQs were immobilized on AuNPs that presented carboxylic acid groups at a density of 10%. The carboxylic acid-presenting AuNPs were incubated with EDC and NHS, affording NHS-activated ester groups. Ciprofloxacin was directly incubated with the NHS-esterpresenting AuNPs to give ciproAuNPs. For the immobilization of enrofloxacin, amine groups were introduced on the AuNPs by the incubation of ethylenediamine with the NHS-ester-presenting AuNPs. The amine-presenting AuNPs were then tethered to enrofloxacin by an amide-coupling reaction to give enroAuNPs (Fig. 2b) . The tri(ethylene glycol) groups on both the AuNPs and chips confer inertness, thereby improving the selectivity by reducing background signals. The tri(ethylene glycol)-terminated alkanethiolate, with a six-carbon chain, which is present in large excess on the AuNPs, acts as an Am-tag to give amplified mass signals, as shown in Fig. 1 .
Next, our strategy was applied to the detection of two FQs, enrofloxacin and ciprofloxacin in a solution. An antibodypresenting gold chip (4 × 4 mm 2 ) was treated with a mixed solution (10 μL) of drug-immobilized AuNPs (0.2 nM) and a standard target solution at various concentrations ranging from 0.05 to 50 mg kg -1 in PB at pH 7.4. After 1 h, the chip was gently rinsed twice with PBS and deionized water, respectively, and dried under a stream of nitrogen. The monolayer was then directly analyzed using LDI-TOF MS without an organic matrix. Figure 3 shows the representative LDI-TOF mass spectra for the detection of enrofloxacin (Fig. 3, left) and ciprofloxacin (Fig. 3,   right) , obtained using our strategy. The LID-TOF mass spectra showed a peak at m/z 553.3 [M + Na] + corresponding to the Am-tag with a high signal-to-noise ratio. Note that sodium adducts of disulfides are the major species that are observed in MALDI spectra of SAMs of alkanethiolates. 30, 31 The target concentration dependence was also clearly observed; the Am-tag intensity gradually decreased with increasing FQ concentration, and became saturated at 50 mg kg -1 . A control experiment using AuNPs coated with bovine serum albumin gave a trace of the Am-tag peak, indicating the high selectivity of our strategy. Note that the spectra in Fig. 3 were normalized using the Am-tag peak in the top spectrum.
Finally, a calibration curve was constructed by linear regression of the signal intensities of the Am-tag in Fig. 3 against the FQ concentration. It is widely accepted that MALDI-TOF MS is not inherently quantitative, and the direct use of mass intensities for quantification is not practical. 32 However, the calibration curve is linear for target concentrations ranging from 0.05 to 50 mg kg -1 as shown in Fig. 4 . This linearity of the calibration curve obtained using our approach, which may be attributed to the absence of an organic matrix in the mass analysis, verifies the validity of our strategy for quantification of the target FQs. 
Conclusions
Here, we report on a new method for detecting two major FQ antibiotics, enrofloxacin and ciprofloxacin. We used AuNPs possessing a large number of small molecules, which functioned as reporters of target materials by affording distinct and amplified LDI-TOF MS signals. The sensitivity of our method is comparable to ELISA and electrophoresis, and may not have an advantage over routine analytical methods such as HPLC, LC/MS, and ELISA in terms of sensitivity. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] However, our approach is advantageous over these methods since it has a short assay time, a simple experimental protocol, and low background signals. We believe that our strategy has wide potential for use as a detection method for small molecules that have corresponding antibodies or capturing agents. It would therefore be a useful analytical tool for detecting and monitoring not only trace levels of many other antibiotics but also a wide range of food-borne hazardous materials, including mycotoxin, synthetic/ natural food additives, and pesticide residues. However, there is a potential problem in using our strategy; targets need to have proper functional groups for immobilization on AuNPs, and any modification via these groups must not significantly affect the binding affinity toward the corresponding antibody or capture agent.
